Document is current
Any future updates will be listed below
-
Authors
Sviderskiy, Vladislav O.
Vasudevaraja, Varshini
Dubois, Luiz Gustavo
Stafford, James
Liu, Elisa K.
Serrano, Jonathan
Possemato, Richard
Snuderl, Matija
-
Funding
Funding for this research was provided by:
NIH (T32GM007308, T32GM115313, CA228202, T32GM007308, T32GM115313, CA228202, R01 GM132491, R01 CA214948, R01 GM132491, R01 CA214948)
the Making Headway Foundation
the Molly Markoff Foundation
Pew Charitable Trusts and the Alexander and Margaret Stewart Trust
American Cancer Society Research
National Institute of Neurological Disorders and Stroke (R01-NS122987)
- License Information
-
More Information
Article History
Received: 16 December 2024
Accepted: 15 February 2025
First Online: 15 March 2025
Declarations
:
: All tumors were collected upon obtaining informed consent approved by Institutional Review Board (IRB#: S12-00865).
: Not applicable.
: M.S. is scientific advisor and shareholder of Heidelberg Epignostix and Halo Dx, and a scientific advisor of Arima Genomics, and InnoSIGN and received research funding from Lilly USA. Other authors declare no conflict of interest.
